IONS — IONIS PHARMACEUTICALS INC catalysts
Next verified catalyst
2026-12-01 — A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Tr · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Proph
Phase 3 · Hereditary Angioedema |
IONS IONIS PHARMACEUTICALS INC | Donidalorsen |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|